SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000885590-15-000043
Filing Date
2015-05-27
Accepted
2015-05-27 15:54:51
Documents
1
Period of Report
2015-05-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3387
  Complete submission text file 0000885590-15-000043.txt   5029
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NORTEL NETWORKS CORPORATION 8200 DIXIE ROAD STE 100 BRAMPTON ONTARIO A6 L6T 5P6
Business Address
STEVENSON KATHARINE BERGHUIS (Reporting) CIK: 0001232227 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 15892363